Insilico's AI drug Rentosertib shows 3-4 year biological age reversal in 12 weeks
NinaDSchick · x · 2026-09-08
- Insilico Medicine's AI-developed drug Rentosertib, now in Phase 3 trials, reportedly reversed biological aging: after 12 weeks of treatment, six independent aging clocks all showed participants measuring 3-4 years younger biologically.
- The paper's senior author calls it the most important publication of his career, presenting it first at Nature AI Healthcare in Paris, with broader implications for clinical trial design.
- If it holds up, this is a landmark for both AI drug discovery and the aging field.
More from AGI Musings
- Researcher notes X's algorithm feeds anti-AI memes, an almost populist cultural wave — RexDouglass · 2026-09-08
- 89% of firms deploy AI but only 6% see real returns, and AI layoffs hit 112,713 — mikeflache · 2026-09-08
- Critic says AI doubters quietly pivoted from 'snake oil' to 'normal technology' after being proven wrong — nitarshan · 2026-09-08
- Astra Driving Blender via Computer Use Could Be AI's Fourth Demand Wave — firstadopter · 2026-09-08
- Jack Clark publishes 'The Thousand and One Faces of Repair,' fiction about fixing misbehaving AIs under 2030s sentience accords — jackclarkSF · 2026-09-08
- Is AI slop okay at work? Debate over raw AI output in communication — oliviaakory · 2026-09-08